Table 2.
CD4 + , CD8 + subtypes of T cells from immunized mice were measured using flow cytometry
Immunization route a | Immunization regimen | CD4 + (%) b | CD8 + (%) b |
---|---|---|---|
Intramuscular vaccination |
PBS |
26.71 ± 1.32 |
21.67 ± 0.82 |
|
pVAX1 |
25.45 ± 1.13 |
22.37 ± 0.98 |
|
pVAX1-MEG-CTXA2/B |
24.56 ± 1.25 |
28.54 ± 0.92 |
Intranasal vaccination |
BRD509 |
25.71 ± 0.64 |
22.37 ± 0.83 |
|
BRD509/pVAX1 |
24.32 ± 1.75 |
26.34 ± 0.93 |
|
BRD509/pVAX1-MEG-CTXA2/B |
24.68 ± 1.43 |
30.01 ± 1.78 |
Intraoral vaccination |
BRD509 |
27.45 ± 1.91 |
24.38 ± 0.98 |
|
BRD509/pVAX1 |
24.32 ± 1.21 |
30.28 ± 0.53 |
BRD509/pVAX1-MEG-CTXA2/B | 25.15 ± 1.55 | 35.55 ± 0.70 |
aMice were immunized by three immunization routes, intramuscular, intraoral, intranasal, on day 0 and day 14 and day 28 with different immunization regimens.
bThe splenocyte culture supernatants taken from mice (n = 3, each group) 2 weeks after the last immunization were stained with FITC-labeled anti-mouse CD8+ monoclonal antibody and PE-labeled anti-mouse CD4+ monoclonal antibody, T lymphocyte subsets were measured using flow cytometry.